Newly Activated Clinical Trials

This is a listing of clinical trials recently activated by the University of Illinois Cancer Center Clinical Trials Office for patient enrollment. Click the study links below to learn details regarding the studies on You can also search for other clinical trials on our website. For more information or questions about a study, email [email protected] or call 312-355-5112.

Protocol Title: GU-01: Glycyrrhizin in Prostate Cancer: A Window-of-Opportunity Clinical and Translational Trial

Sponsor: University of Illinois Chicago (UIC)

Principal Investigator: Natalie Reizine, MD

Natalie Reizine photo

Protocol Title: S2206: Phase III Trial of Neoadjuvant Durvalumab (NSC 778709) plus Chemotherapy versus Chemotherapy Alone for Adults with MammaPrint Ultrahigh (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer.

Sponsor: SWOG

Principal Investigator: Kent Hoskins, MD

Photo of Kent Hoskins

Protocol Title: IOV-MEL-301: A Phase 3, Multicenter, Randomized, Open-Label, Parallel Group, Treatment Study to Assess the Efficacy and Safety of the Lifileucel (LN-144, Autologous Tumor Infiltrating Lymphocytes [TIL]) Regimen in Combination With Pembrolizumab Compared With Pembrolizumab Monotherapy in Participants With Untreated, Unresectable or Metastatic Melanoma

Sponsor: Iovance Biotherapeutics, Inc.

Principal Investigator: Ryan Nguyen, DO

Photo of Ryan Nguyen, DO

Protocol Title: A092105: Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy

Sponsor: Alliance

Principal Investigator: Ameen Salahudeen, MD, PhD

Photo of Ameen Salahudeen, PhD, MD

Protocol Title: IMbrave152: A Phase III, Randomized Double-Blind, Placebo-Controlled Study Evaluating Atezolizumab And Bevacizumab, With or Without Tiragolumab, In Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

Sponsor: F. Hoffmann-La Roche Ltd

Principal Investigator: Shikha Jain, MD

Photo of Shikha Jain

Translate »